Skip to main content
SpringerLink
Log in

Association of CSF glucose concentration with neurosyphilis diagnosis

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

The most specific criterion for diagnosing neurosyphilis is a reactive CSF VDRL. Unfortunately, there are in Europe, including Poland small number of specialized laboratories for serological diagnosis of syphilis. Thus, CSF serology results are obtained with delay. Therefore, the decision on recommended therapy for neurosyphilis is taken on the basis of CSF basic tests. In this paper we attempt to determine the utility of CSF glucose concentration and its cut-off values in prediction of asymptomatic neurosyphilis. CSF and blood were collected from 55 HIV-uninfected patients with syphilis of unknown duration. Patients with neurosyphilis (14.5%) were characterized by higher CSF pleocytosis (p<0.0001), elevated CSF protein concentration (p<0.05) and lower CSF glucose concentration (p<0.0001). Multivariate regression analysis identified CSF pleocytosis and CSF glucose concentration as the two independent predictors of reactive CSF VDRL (p<0.0001). In the selected group of patients with CSF pleocytosis ≥5/µL (n=25) CSF glucose concentration ≤2.72 mmol/L was associated with 100% sensitivity (95%CI: 63–100%) and 100% specificity (95%CI: 75.3–100%) for reactive CSF VDRL. CSF glucose concentration may be particularly useful as a predictive marker of neurosyphilis in HIV uninfected patients with syphilis of unknown duration with CSF plecytosis ≥5/µL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Marra MC, Maxwell CL, Tantalo LC et al. Normalization of serum rapid plasma regain titers predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. CID. 2008; 47: 893–899

    Article  Google Scholar 

  2. Lukehart SA, Hook EW 3rd, Baker-Zander SA et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med. 1988; 109: 855–862

    PubMed  CAS  Google Scholar 

  3. Golden R, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA. 2003; 290: 1510–1514

    Article  PubMed  CAS  Google Scholar 

  4. Wharton M, Chorba TL, Vogt RL, et al.: Case definitions for public health surveillance. MMWR Recomm Rep 1990, 39: 1–43

    PubMed  CAS  Google Scholar 

  5. Moore JE, Hopkins H. Asymptomatic neurosyphilis. VI The prognosis of early and late asymptomatic neurosyphilis. JAMA. 1930; 95: 1637–1641

    Article  Google Scholar 

  6. Goh BT, van Voorst Vader PC. European guideline for the management of syphilis. Int J STD AIDS. 2001; 12: 14–27

    Article  PubMed  Google Scholar 

  7. Marra CM. Déjà vu all over again: When to perform a lumbar puncture in HIV-infected patients with syphilis. Sex Transm Dis. 2007; 34: 145–146

    Article  PubMed  Google Scholar 

  8. Marra CM, Maxwell CL, Smith SL et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. JID. 2004; 189: 369–376

    Article  PubMed  Google Scholar 

  9. Ghanem KG. Neurosyphilis: A historical perspective and review. CNS Neurosc Ther. 2010; 16: e157–e168

    Article  Google Scholar 

  10. Ropper AH, Samuels MA. Chapter 2. Special Techniques for Neurologic Diagnosis (Chapter). Ropper AH, Samuels MA: Adams and Victor’s Principles of Neurology, 9e. Available at: http://www.accessmedicine.com/content.aspx?aID=3630099. Accessed July 8, 2011

  11. Larsen SA, Stiener BM, Rudolph AL. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev. 1995; 8: 1–21

    PubMed  CAS  Google Scholar 

  12. Sexually Transmitted Diseases Treatment Guidelines 2002; Centres for Disease Control and Prevention. MMWR Recomm Rep. 2001; 51: 1–78

    Google Scholar 

  13. Mcgeeney T, Yount F, Hinthorn DR, Liu C. Utility of the FTA-ABS test of cerebrospinal-fluid in the diagnosis of neurosyphilis. Sex Transm Dis. 1979; 6: 195–198

    Article  PubMed  CAS  Google Scholar 

  14. Chauhan M, Serisha B, Sankar KN et al. Audit of the use of benzathine penicillin, post-treatment syphilis serology and partner notification of patients with early infectious syphilis. Int J STD AIDS 2006; 17: 200–202

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Jagiellonian University Medical College, Skawinska 8 Street, 31-066, Cracow, Poland

    Maciej Pastuszczak, Anna Wojas-Pelc & Andrzej K. Jaworek

Authors
  1. Maciej Pastuszczak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Wojas-Pelc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrzej K. Jaworek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maciej Pastuszczak.

About this article

Cite this article

Pastuszczak, M., Wojas-Pelc, A. & Jaworek, A.K. Association of CSF glucose concentration with neurosyphilis diagnosis. cent.eur.j.med 8, 48–51 (2013). https://doi.org/10.2478/s11536-012-0060-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-012-0060-6

Keywords

Search

Navigation